Next Article in Journal
Phytosomes with Persimmon (Diospyros kaki L.) Extract: Preparation and Preliminary Demonstration of In Vivo Tolerability
Previous Article in Journal
Nanoparticle- and Nanoporous-Membrane-Mediated Delivery of Therapeutics
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessArticle

β-Cyclodextrin as a Functional Excipient Used for Enhancing the Diminazene Aceturate Bioavailability

1
Centre of Advanced Research in Bionanoconjugates and Biopolymers, “Petru Poni’’ Institute of Macromolecular Chemistry, 41A Aleea Grigore Ghica Voda, 700487 Iasi, Romania
2
“Grigore T. Popa”, University of Medicine and Pharmacy, 16 Strada Universitatii, 700115 Iasi, Romania
3
Ion Ionescu de la Brad, University of Agricultural Sciences and Veterinary Medicine, 8 Aleea Sadoveanu, 700489 Iasi, Romania
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2019, 11(6), 295; https://doi.org/10.3390/pharmaceutics11060295
Received: 16 May 2019 / Revised: 16 June 2019 / Accepted: 19 June 2019 / Published: 22 June 2019
  |  
PDF [5916 KB, uploaded 22 June 2019]
  |  

Abstract

In this study, we proposed formulations of diminazene aceturate (DA) designed to improve its bioavailability and to maximize the therapeutic index in animals by overcoming the rapid degradation under the acidic pH of the stomach. An important consequence is the fact that its amount in the bloodstream is close to the administered dose. This was made possible by incorporating DA into the β-cyclodextrin’s (βCD) cavity in a molar ratio of 1:1. The structure of the resulted inclusion complex was established by Raman, DSC, and Wide-Angle X ray Diffraction (WAXD) in solid state and by 1H-NMR and H-H ROESY in aqueous solutions. The stoichiometry of the DA:βCD inclusion complex was obtained by using the continuous variation method (Job’s plot), considering the chemical shifts variations of protons from both DA and βCD compounds in 1H-NMR spectra. The biological activity was estimated in vitro by antioxidant activity and in vivo by comparing the bioavailability of parent DA and its inclusion complexes after a single dose administration in Wistar rats by using the HPLC method on their blood plasma. In vitro tests showed an improved antioxidant activity. In vivo tests have shown that the DA concentration is always much higher in blood plasma of rats when DA:βCD inclusion complex of 1:1 molar ratio was administered (i.e., at 60 min, DA is around 11 and 3 times higher when DA:βCD inclusion complex of 1:1 molar ratio was administered than the parent DA one and DA:βCD lyophilized mixture of 1:2 molar ratio, respectively). View Full-Text
Keywords: diminazene aceturate; cyclodextrins inclusion complex; antioxidant; bioavailability diminazene aceturate; cyclodextrins inclusion complex; antioxidant; bioavailability
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Marangoci, N.; Timpu, D.; Corciova, A.; Mircea, C.; Petrovici, A.-R.; Nicolescu, A.; Ursu, E.-L.; Nastasa, V.; Bostanaru, A.-C.; Mares, M.; Pertea, M.; Pinteala, M. β-Cyclodextrin as a Functional Excipient Used for Enhancing the Diminazene Aceturate Bioavailability. Pharmaceutics 2019, 11, 295.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top